市場調查報告書
商品編碼
1525475
全球數位病理學市場評估:按產品類型、應用、最終用戶、地區、機會、預測(2017-2031)Digital Pathology Market Assessment, By Product, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球數位病理市場規模預計將從 2023 年的 10 億美元增至 2031 年的 25.7 億美元,2024-2031 年預測期間複合年增長率為 12.50%。該市場是醫療IT和生物技術產業的重要組成部分,是醫療市場中成長速度最快的。數位病理技術的日益採用、人工智慧和機器學習的整合以及慢性病盛行率的增加等因素正在推動市場發展。
數位病理學涉及從數位標本載玻片收集的數據的管理。數位病理學使用基於電腦技術的虛擬顯微鏡。由玻璃製成的數位幻燈片可以在電腦螢幕上管理、分享、檢查和分析。現代病理學需要新的方法,而數位病理學提供了許多好處,包括改進的分析、更少的錯誤、更好的視覺化、更流暢的工作流程和更短的周轉時間。機器學習和人工智慧在醫學領域的進步正在擴展數位病理學領域,並且使用全玻片成像 (WSI) 的診斷醫學應用正在獲得認可。這些應用的目標是實現準確且廉價的疾病診斷、預後和預測。
AGFA Healthcare NV 和 Corista LLC 宣佈於 2024 年 7 月推出北美病理數位轉型整合解決方案。這項先進技術幫助病理部門克服從模擬環境過渡到數位環境的課題。這些課題包括降低複雜性、加強臨床協作和提高營運效率。AGFA 的企業影像平台可讓您跨多個服務線部署安全且可自訂的影像整合方法。
慢性病增加將加速市場需求
糖尿病和心臟病等長期健康問題的增加給醫院及其住院部帶來了巨大的壓力。智慧型手機應用程式和醫療設備等行動醫療技術使患者能夠監控自己的健康狀況、照顧自己並定期在家中與醫生交談。British Heart Foundation的報告顯示,全球約有2億人患有冠狀動脈疾病(CAD),其中男性佔冠心病患者的57.89%,女性佔42.11%。根據IDF(International Diabetes Federation)的數據,全球有超過 5.37 億成年人患有糖尿病。
整合人工智慧和機器學習發展數位病理市場
隨著越來越多的實驗室使用人工神經網路來增強分析,科技的進步使得數位病理學測試越來越受歡迎。全玻片成像(WSI)是其在數位病理學中應用的一個突出例子。顯微鏡載玻片由 WSI 進行數位掃瞄並載入到電腦中。然後,用戶可以使用影像增強和數位轉換技術進行基於人工智慧的分析。開發有效的癌症治療方法一直是醫學專業人員面臨的問題。儘管傳統的活檢結果非常準確,但處理和解釋數據需要很長時間。人工智慧系統可以快速收集和分析必要的數據,做出準確的癌症診斷並提供結果。2024年5月,Microsoft宣佈與華盛頓大學和Providence健康網路合作,推出數位病理診斷的全幻燈片AI模型。研究團隊提出了一種機器學習模型,該模型基於現實世界中進行的全玻片組織分析中最大的人工智慧培訓項目之一。
本報告針對全球數位病理市場進行研究與分析,提供市場規模與預測、區域市場前景、市場動態、競爭格局等。
Global digital pathology market is projected to witness a CAGR of 12.50% during the forecast period 2024-2031, growing from USD 1.00 billion in 2023 to USD 2.57 billion in 2031. The global digital pathology market is an important part of the healthcare IT and biotechnology industry, accounting for one of the fastest growth rates in the healthcare market. Factors are driving the market such as increasing adoption of digital pathology technologies, integration of AI and machine learning, and growing prevalence of chronic diseases.
Digital pathology deals with the management of data gathered from digital specimen slides. Virtual microscopy is used in digital pathology, using computer-based technologies. Digital slides made from glass can be managed, shared, examined, and analyzed on a computer screen. Modern pathologies need new approaches as digital pathology offers numerous benefits such as improved analysis, reduced errors, better views, smooth workflow, and reduced turnaround times. Due to the advancements in machine learning and artificial intelligence in healthcare, the field of digital pathology is expanding and recognizing applications in diagnostic medicine using whole-slide imaging (WSI). The goal of these applications is to achieve accurate and affordable disease diagnosis, prognosis, and prediction.
AGFA Healthcare N.V. and Corista LLC announced the launch of their integrated solution for digital transformation in pathology in North America in July 2024. This advanced technology helps pathology departments overcome the difficulties that occur in moving from an analog to a digital environment. These difficulties involve reducing complexity, enhancing clinical cooperation, and facilitating operational efficiency. The recognized enterprise imaging platform from AGFA makes it possible to implement a safe, customizable picture consolidation approach across several service lines.
Increasing Prevalence of Chronic Diseases to Accelerate the Market Demand
The rise in long-term health problems, such as diabetes and heart issues, puts a lot of pressure on hospitals and their inpatient units. The burden makes people want mobile health (mHealth) options that can help them handle ongoing health conditions better. mHealth technologies such as phone apps and medical devices let patients keep an eye on their health from home, take care of themselves, and talk to their doctors on a regular basis. As per a report from British Heart Foundation, around 200 million people have coronary artery disease (CAD), men and women constituting 57.89% and 42.11%, respectively of the global coronary artery disease patients globally. As per IDF (International Diabetes Federation), more than 537 million adults are living with diabetes globally.
Integration of Artificial Intelligence and Machine Learning to Evolve Digital Pathology Market
Digital pathology has become increasingly popular as a result of technology advancements, as more laboratories use artificial neural networks to enhance their analysis. Whole slide images (WSI) are a prominent example of applications in digital pathology. The microscope slide is digitally scanned by WSI and loaded into a computer. After that, users can use picture improvement and digital transformation methods for AI-based analysis. It has always been a problem for medical professionals to develop effective cancer treatments. The findings of a traditional biopsy are quite accurate, but processing and interpreting the data takes a long time. Artificial intelligence systems can quickly collect and analyze the necessary data, provide accurate cancer diagnoses, and produce results. In May 2024, Microsoft announced its collaboration with the University of Washington and Providence health network with the aim of launching whole-slide AI model for digital pathology. The researchers presented a machine learning model based on one of the most extensive AI training projects in whole-slide tissue analysis conducted in real-world settings.
Device Segment Dominates the Global Digital Pathology Market
The device segment had a dominant share of the global digital pathology market. It is expected to maintain at a lucrative pace throughout the forecast period. The scanner and slide management system are part of the device segment. The growing use of digital pathology for higher-resolution imaging in academic research projects is one of the major reasons behind the segment's growth. The VENTANA DP 600 slide scanner, a next-generation high-capacity device by F. Hoffmann-La Roche Ltd. that produces high-resolution digital pictures of stained tissue samples, assists in cancer diagnosis and treatment planning after the CE mark approval in June 2022.
North America Dominates the Global Digital Pathology Market
In 2023, North America held a dominant position in the global digital pathology market. This was attributed to several factors, including the development of technologically advanced pathologies due to government initiatives, ongoing deployment of R&D investments, presence of healthcare regulatory bodies, rising adoption of digital imaging, and the presence of key market players in the region who were focused on improving living and health conditions of individuals with chronic diseases. To participate in the Early Access Program, PathAI released AISight, a digital pathology platform, in March 2023 in top health systems of 13 nations, reference laboratories, medical facilities, and independent pathology organizations. Additionally, the market is growing due to the growing use of digital pathology in academic research and illness diagnostics. In June 2024, Roche announced that its whole-slide imaging system, the Roche Digital Pathology Dx, received FDA 510(k) approval. The technology analyzes and interprets digital images of scanned pathology slides to facilitate pathologists' diagnostic process. Roche is dedicated to make routine medical diagnosis possible with its digital pathology solutions, and the approval was the first step in that direction.
Future Market Scenario (2024-2031F)
A completely digital workflow from electronic microscopes to cloud-based storage and analysis is expected to accelerate digital pathology market in the forecast period. This will make remote collaboration possible and turn diagnosis faster and more effective.
Artificial intelligence and deep learning technologies will automate tasks, such as pattern recognition and computer-aided diagnosis, in digital pathology market.
More advanced applications, such as forecasting genetic alterations and treatment response based on anatomical characteristics of tissue samples, will be possible through the integration of digital pathology with AI and machine learning.
Digital pathology will enable pathologists to access and interpret slides remotely, which is crucial when there is a projected shortage of pathologists in the future.
Key Players Landscape and Outlook
Several biotechnology companies and IT companies are growing in the digital pathology market by planning and adopting new strategies. They are complying with new strategic initiatives for digital pathology technologies to increase their market presence. New agreements, contracts, acquisitions mergers, investments, and partnerships are major ways through which the market players are trying to achieve a higher market share.
Philips and Amazon Web Services announced their partnership in March 2024 to scale its cloud storage for digital pathology solutions. By enabling more pathology laboratories to use digital processes to boost productivity, Philips and AWS will progress digital pathology and assist pathology labs in effectively managing, storing, and analyzing increasing amounts of digital pathology data.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.